House committee questions Biogen drug approval process
December 30, 2022 at 00:08 AM EST
The FDA's approval process of Biogen's Alzheimer's drug was questioned in a Congressional report released Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|